THC / CBD Testing

The use, acceptance and legislation of medicinal cannabis continues to evolve rapidly. Nowadays there are two types of cannabis products: medicinal products with marketing authorization and cannabis (magistral) preparations.

Several countries, such as Israel, Canada, Germany, and the Netherlands, have already changed their regulations to allow patient access to medical cannabis and related products. However, the regulation of cannabis and cannabinoids for medical purposes around the world presents itself as a complex system of approaches. To date there is still no harmonized EU standard or pharmacopoeia monograph for medical cannabis and therefore products follow national legislations and local guidelines. Furthermore, several European countries have also published specific pharmacopoeia monographs for cannabis flowers (e.g. the German DAB Monograph, the Draft DK Monograph) and extracts (German draft monograph).

For this reason it is especially important to have a specific quality standard in place. The quality standard should include a control to any contamination or adulteration as derived from the use of pesticides, assay limits for active ingredients, microbiological contamination, heavy metals, absence of aflatoxins, ochratoxin A, foreign matter, residual solvents, and other specific tests based on the risk analysis of the products.

Neotron's proposal

To date the Neotron Pharma department is active on the analysis of THC Δ8/ Δ9 and CBD on finished pharmaceutical grade products, botanical extracts, and CBD oil.

Among the activities offered we include:

• DAC monography for Cannabidiol
• Method validation for Assay (CBD) and THC Impurities on FP

The laboratory can support the customer from an analytical point of view, requesting the appropriate ministerial authorizations for the handling of substances, throughout the supply chain from raw material to the finished product.

Request an Analysis

To learn more about our services, or to request an analysis for your business, please don't hesitate to contact us.